Previous Close | 6.20 |
Open | 6.20 |
Bid | 6.12 x 2200 |
Ask | 6.37 x 1800 |
Day's Range | 6.16 - 6.27 |
52 Week Range | 5.31 - 7.26 |
Volume | |
Avg. Volume | 782,448 |
Market Cap | 670.304M |
Beta (5Y Monthly) | 1.96 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.27 |
Earnings Date | May 01, 2024 - May 06, 2024 |
Forward Dividend & Yield | 0.24 (3.85%) |
Ex-Dividend Date | Feb 14, 2024 |
1y Target Est | 7.75 |
Subscribe to Yahoo Finance Plus to view Fair Value for INN
Innocan Pharma Corporation (the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that it has closed its previously announced non-brokered private placement offering (the "Offering") of units of the Company (the "Units"), pursuant to which the Company issued 7,952,840 Units at a price of $0.25 per Unit (the "Offering Price") for aggregate gross proceeds of $1,988,210.
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the development of drug delivery technologies using CBD for the pharmaceutical and biotechnology industries, is pleased to announce the following:
Summit Hotel Properties, Inc. (NYSE:INN) Q4 2023 Earnings Call Transcript February 29, 2024 Summit Hotel Properties, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank you for standing by. Welcome to the Summit Hotel Properties Q4 […]